Antibody–Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers | Journal of the American Chemical Society
![Antibody–Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers | Journal of the American Chemical Society Antibody–Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers | Journal of the American Chemical Society](https://pubs.acs.org/cms/10.1021/jacs.2c02537/asset/images/large/ja2c02537_0003.jpeg)
Antibody–Invertase Fusion Protein Enables Quantitative Detection of SARS-CoV-2 Antibodies Using Widely Available Glucometers | Journal of the American Chemical Society
![Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells | Science Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells | Science](https://www.science.org/cms/10.1126/science.abj9853/asset/e8c19489-df21-4ee9-a689-27cfd8c19385/assets/images/large/science.abj9853-fa.jpg)
Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells | Science
![Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection | Science Immunology Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abq3511/asset/bad0665b-d8c7-472c-83a5-f8ff41fbf541/assets/images/large/sciimmunol.abq3511-f1.jpg)
Recall of preexisting cross-reactive B cell memory after Omicron BA.1 breakthrough infection | Science Immunology
![Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention - ScienceDirect Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0169409X20300971-ga1.jpg)
Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention - ScienceDirect
SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants
![Detecting anti–SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion | Science Advances Detecting anti–SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion | Science Advances](https://www.science.org/cms/10.1126/sciadv.abn7424/asset/bd62d143-b81c-45ea-9fa8-8800b217b66a/assets/images/large/sciadv.abn7424-f1.jpg)
Detecting anti–SARS-CoV-2 antibodies in urine samples: A noninvasive and sensitive way to assay COVID-19 immune conversion | Science Advances
![Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy | British Journal of Cancer Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2015.174/MediaObjects/41416_2015_Article_BFbjc2015174_Fig1_HTML.jpg)
Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy | British Journal of Cancer
![Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences | eLife Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences | eLife](https://iiif.elifesciences.org/lax/74153%2Felife-74153-fig1-v2.tif/full/,1500/0/default.jpg)
Absolute quantitation of individual SARS-CoV-2 RNA molecules provides a new paradigm for infection dynamics and variant differences | eLife
![TropicalMed | Free Full-Text | Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review TropicalMed | Free Full-Text | Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review](https://www.mdpi.com/tropicalmed/tropicalmed-07-00081/article_deploy/html/images/tropicalmed-07-00081-g001-550.jpg)
TropicalMed | Free Full-Text | Characteristics of COVID-19 Breakthrough Infections among Vaccinated Individuals and Associated Risk Factors: A Systematic Review
![Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV) | eLife Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV) | eLife](https://iiif.elifesciences.org/lax:83201%2Felife-83201-fig2-v2.tif/full/1500,/0/default.jpg)
Pharmacometrics of high-dose ivermectin in early COVID-19 from an open label, randomized, controlled adaptive platform trial (PLATCOV) | eLife
![SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants | mBio SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants | mBio](https://journals.asm.org/cms/10.1128/mbio.01784-22/asset/f49c90a2-f77a-44c8-aa5d-25e98492810d/assets/images/medium/mbio.01784-22-f001.gif)
SARS-CoV-2 Spike-Binding Antibody Longevity and Protection from Reinfection with Antigenically Similar SARS-CoV-2 Variants | mBio
![Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial - The Lancet Neurology Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial - The Lancet Neurology](https://www.thelancet.com/cms/attachment/5c773b96-c009-4b38-aeb7-a7884b3b5784/gr1_lrg.gif)